Literature DB >> 5453613

[Clinical experimental studies on the blood pressure reducing effect of verapamil].

W D Brittinger, A Schwarzbeck, K W Wittenmeier, W D Twittenhoff, B Stegaru, W Huber, R W Ewald, G E von Henning, M Fabricius, M Strauch.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5453613     DOI: 10.1055/s-0028-1108744

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


× No keyword cloud information.
  17 in total

1.  Effect of verapamil in obstructive airways disease.

Authors:  T Ringqvist
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

2.  [Effect of verapamil on coronary blood flow, oxygen utilisation and carbon dioxide production in human heart].

Authors:  W Rudolph; J Kriener; W Meister
Journal:  Klin Wochenschr       Date:  1971-09-01

Review 3.  Calcium antagonists. Clinical use in the treatment of systemic hypertension.

Authors:  C Spivack; S Ocken; W H Frishman
Journal:  Drugs       Date:  1983-02       Impact factor: 9.546

4.  The role of autonomic nervous system in the action of verapamil on the sinus node in man.

Authors:  G Breithardt; L Seipel; E Wiebringhaus; F Loogen
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

5.  Haemodynamic effects of intravenous verapamil at rest and during exercise in subjectively healthy middle-aged men.

Authors:  J H Atterhög; L G Ekelund
Journal:  Eur J Clin Pharmacol       Date:  1975-06-13       Impact factor: 2.953

6.  Diltiazem and verapamil: functional antagonism of exogenous noradrenaline and angiotensin II in man.

Authors:  D Magometschnigg; H Hörtnagl; H Rameis
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 7.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 8.  Verapamil: a review of its pharmacological properties and therapeutic use.

Authors:  B N Singh; G Ellrodt; C T Peter
Journal:  Drugs       Date:  1978-03       Impact factor: 9.546

9.  Does verapamil have a clinically significant antihypertensive effect?

Authors:  O L Pedersen
Journal:  Eur J Clin Pharmacol       Date:  1978-03-17       Impact factor: 2.953

10.  Effects of verapamil on pulmonary haemodynamics during hypoxaemia, at rest, and during exercise in patients with chronic obstructive pulmonary disease.

Authors:  S E Brown; G S Linden; R R King; G P Blair; D W Stansbury; R W Light
Journal:  Thorax       Date:  1983-11       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.